0000950142-12-000844.txt : 20120405
0000950142-12-000844.hdr.sgml : 20120405
20120405185335
ACCESSION NUMBER: 0000950142-12-000844
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120404
FILED AS OF DATE: 20120405
DATE AS OF CHANGE: 20120405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD
CENTRAL INDEX KEY: 0001120478
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52120
FILM NUMBER: 12746815
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001368514
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 562590442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 65 COMMERCE WAY
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
BUSINESS PHONE: (201) 478-5552
MAIL ADDRESS:
STREET 1: 65 COMMERCE WAY
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
FORMER COMPANY:
FORMER CONFORMED NAME: R&R ACQUISITION VI, INC
DATE OF NAME CHANGE: 20060707
4
1
es1200529_4-goldstein.xml
OWNERSHIP DOCUMENT
X0305
4
2012-04-04
0
0001368514
ADMA BIOLOGICS, INC.
NONE
0001120478
GOLDSTEIN DOV A MD
888 SEVENTH AVENUE
30TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Stock Option
9.60
2012-04-04
4
A
0
13258
0
A
2022-04-03
Common Stock
13258
13258
D
25% of these options will become exercisable on April 4, 2013, and the remainder will become exercisable in equal monthly installments on the 29th of each month until April 4, 2016.
These stock options are held by Dr. Goldstein for the benefit of Aisling Capital LLC. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
/s/ Dov A. Goldstein
2012-04-05